A Study to Assess the Safety and Immunogenicity of a New Influenza Vaccine Candidate MVA-NP+M1 in Healthy Adults

NCT00942071 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
58
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Oxford

Collaborators